- Home
- ONCY vs PDSB Comparison
ONCY vs PDSB Comparison
Compare ONCY & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- PDSB
- Stock Information
- Founded
- ONCY 1998
- PDSB 2005
- Country
- ONCY Canada
- PDSB United States
- Employees
- ONCY N/A
- PDSB N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- PDSB Health Care
- Exchange
- ONCY Nasdaq
- PDSB Nasdaq
- Market Cap
- ONCY 49.1M
- PDSB 43.1M
- IPO Year
- ONCY 1999
- PDSB N/A
- Fundamental
- Price
- ONCY $0.52
- PDSB $1.20
- Analyst Decision
- ONCY Strong Buy
- PDSB Strong Buy
- Analyst Count
- ONCY 3
- PDSB 3
- Target Price
- ONCY $4.33
- PDSB $10.00
- AVG Volume (30 Days)
- ONCY 333.0K
- PDSB 203.4K
- Earning Date
- ONCY 05-14-2025
- PDSB 05-14-2025
- Dividend Yield
- ONCY N/A
- PDSB N/A
- EPS Growth
- ONCY N/A
- PDSB N/A
- EPS
- ONCY N/A
- PDSB N/A
- Revenue
- ONCY N/A
- PDSB N/A
- Revenue This Year
- ONCY N/A
- PDSB N/A
- Revenue Next Year
- ONCY N/A
- PDSB N/A
- P/E Ratio
- ONCY N/A
- PDSB N/A
- Revenue Growth
- ONCY N/A
- PDSB N/A
- 52 Week Low
- ONCY $0.47
- PDSB $0.85
- 52 Week High
- ONCY $1.53
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- ONCY 41.53
- PDSB 48.97
- Support Level
- ONCY $0.54
- PDSB $1.20
- Resistance Level
- ONCY $0.65
- PDSB $1.27
- Average True Range (ATR)
- ONCY 0.04
- PDSB 0.10
- MACD
- ONCY -0.00
- PDSB -0.00
- Stochastic Oscillator
- ONCY 13.36
- PDSB 39.27
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.